Ceftriaxone Injection

Ceftriaxone Injection Manufacturing Process by Den Mark Pharmaceuticals Pvt. Ltd. (as per WHO GMP)

Top-quality Ceftriaxone Injection (100 mg) is a pharmaceutical product used primarily for treating bacterial infections. Ceftriaxone is a broad-spectrum cephalosporin antibiotic that interferes with the bacteria's cell wall synthesis, leading to their death.

Den Mark Pharmaceuticals Pvt. Ltd., a pharmaceutical exporter in India, manufactures Ceftriaxone Injection following strict WHO Good Manufacturing Practices (GMP) guidelines. This ensures a high-quality sterile product for patient use.

1. Starting Materials and Raw Material Management:

  • All incoming raw materials (starting chemicals, solvents, filters) are thoroughly inspected against pre-defined specifications and accompanied by certificates of analysis.
  • Materials are quarantined until qualified by the Quality Control (QC) department.
  • A documented receiving procedure ensures proper labeling, storage under defined conditions, and traceability throughout manufacturing.

2. Ceftriaxone Synthesis:

  • A designated clean area equipped with appropriate air handling and filtration systems is used for the synthesis.
  • Following approved production instructions, trained personnel weigh and transfer accurate quantities of starting materials into a sterilized reaction vessel.
  • The reaction proceeds under controlled temperature, pressure, and pH conditions.
  • In-process controls are performed at defined stages to monitor reaction progress and ensure quality.

3. Isolation and Purification:

  • Upon reaction completion, the crude Ceftriaxone undergoes a series of purification steps, such as filtration, crystallization, and washing, to remove impurities and unwanted byproducts.
  • Specific solvents and techniques are employed to achieve high purity per pre-determined specifications.
  • Specific solvents and techniques are employed to achieve high purity per pre-determined specifications.

4. Crystallization and Drying:

  • The purified Ceftriaxone is crystallized under controlled conditions to achieve a uniform crystal size and ensure consistent dissolution properties for the final injection.
  • The wet crystals are separated from the solution by filtration using pre-sterilized filters.
  • The crystals are carefully dried in a controlled environment to remove residual solvents and moisture to a pre-defined level.

5. Filling and Finishing:

  • A separate sterile filling line with isolators and automated equipment is used for aseptic filling.
  • Vials and stoppers are pre-sterilized and dehydrogenated.
  • Accurately weighed sterile Ceftriaxone powder is filled into sterilized vials under aseptic conditions.
  • A vacuum is applied to remove air and ensure product integrity.
  • Pre-sterilized stoppers are inserted into the vials using a crimping machine to form an airtight seal.
  • Vials are labeled with product information, batch number, and expiry date.

6. Sterilization and Packaging:

  • Depending on the formulation, filled and sealed vials undergo terminal sterilization using a validated method, such as steam sterilization or lyophilization (freeze-drying).
  • The sterilization process ensures the complete elimination of any microbial contaminants.
  • Sterilized Ceftriaxone Injection (100 mg) vials are inspected for leaks and visual defects.
  • Ceftriaxone Injection (100 mg) Vials are then packed into cartons with desiccant inserts for moisture control and labeled with the secondary packaging information.

7. Quality Control and Release:

  • Throughout manufacturing, QC performs extensive testing on samples according to pre-defined specifications.
  • Testing includes chemical identity, purity (by chromatography), potency (by bioassay), sterility testing, and physical characteristics of the powder.
  • The final Ceftriaxone Injection (100 mg) is released for sale only after all QC tests meet pre-defined acceptance criteria.

8. Documentation and Record Keeping:

  • All manufacturing steps, including raw material usage, production logs, equipment calibration records, and QC results, are meticulously documented.
  • These records are maintained for a defined period to ensure complete traceability and facilitate future audits.

Den Mark Pharmaceuticals Pvt. Ltd. continually manufactures sterile, high-quality Ceftriaxone Injections for patient usage by following these extensive processes and stringent WHO GMP criteria.